BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28050695)

  • 1. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.
    Gierada DS; Pinsky PF; Duan F; Garg K; Hart EM; Kazerooni EA; Nath H; Watts JR; Aberle DR
    Eur Radiol; 2017 Aug; 27(8):3249-3256. PubMed ID: 28050695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
    Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
    JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
    Thomas A; Pattanayak P; Szabo E; Pinsky P
    Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses.
    Rampinelli C; Minotti M; Ancona E; Preda L; Bertolotti R; Summers P; Raimondi S; Bagnardi V; Bellomi M
    Eur Radiol; 2019 Jul; 29(7):3862-3870. PubMed ID: 31062136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks.
    Robbins HA; Cheung LC; Chaturvedi AK; Baldwin DR; Berg CD; Katki HA
    J Thorac Oncol; 2022 Feb; 17(2):252-263. PubMed ID: 34648946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer.
    Munden RF; Chiles C; Boiselle PM; Sicks JD; Aberle DR; Gatsonis CA
    J Thorac Oncol; 2019 Sep; 14(9):1538-1546. PubMed ID: 31295576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening.
    Scholten ET; Horeweg N; de Koning HJ; Vliegenthart R; Oudkerk M; Mali WP; de Jong PA
    Eur Radiol; 2015 Jan; 25(1):81-8. PubMed ID: 25187382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.
    Schabath MB; Massion PP; Thompson ZJ; Eschrich SA; Balagurunathan Y; Goldof D; Aberle DR; Gillies RJ
    PLoS One; 2016; 11(8):e0159880. PubMed ID: 27509046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules.
    Yip R; Yankelevitz DF; Hu M; Li K; Xu DM; Jirapatnakul A; Henschke CI
    Radiology; 2016 Nov; 281(2):589-596. PubMed ID: 27378239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of lung cancer using ultra-low-dose computed tomography in coronary CT angiography scans among patients with suspected coronary heart disease.
    Zanon M; Pacini GS; de Souza VVS; Marchiori E; Meirelles GSP; Szarf G; Torres FS; Hochhegger B
    Lung Cancer; 2017 Dec; 114():1-5. PubMed ID: 29173759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
    Yip R; Henschke CI; Yankelevitz DF; Smith JP
    Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lung cancer screening with low dose CT requires careful consideration].
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Thomsen LH; Wille MM; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.